FDA Panel Green Lights Approval of Collegium's Painkiller Pharamceutical company Collegium is one step closer to gaining full approval of their new opioid painkiller. An FDA panel has raised the green light to move the review of the drug to its final stages. by Rina Marie Doctor
Healthy Living/Wellness FDA Drug Approval Numbers Through the Roof. Big Pharma Sees New 18-Year High by Dianne Depra